UBS Downgrades Charles River Labs (CRL) to Sell
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
UBS downgraded Charles River Labs (NYSE: CRL) from Neutral to Sell with a price target of $78.00 (from $83.00).
Shares of Charles River Labs closed at $84.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- General Electric (GE) PT Lowered to $35 at UBS Following 4Q Report
- UPDATE: Seaport Global Securities Upgrades Flowserve Corp. (FLS) to Buy
- Teradyne (TER) PT Raised to $28 at Deutsche Bank; Reiterates Buy
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades, Hot Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!